市場調査レポート
商品コード
1386274
自己幹細胞および非幹細胞ベース治療市場レポート:2030年までの動向、予測、競合分析Autologous Stem Cell and Non-Stem Cell Based Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
自己幹細胞および非幹細胞ベース治療市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
自己幹細胞および非幹細胞ベース治療動向と予測
世界の自己幹細胞および非幹細胞ベース治療市場は、2024年から2030年までのCAGRが10.2%で、2030年までに推定130億米ドルに達すると予測されます。この市場の主な促進要因は、低侵襲治療に対する需要の高まり、幹細胞および非幹細胞を用いた治療法の急速な技術進歩、再生医療の利用を促進するための政府支援の高まりです。世界の自己幹細胞および非幹細胞ベース治療市場の将来は、病院や外来手術センター市場における機会によって有望視されています。
自己幹細胞および非幹細胞ベース治療市場の洞察
Lucintelの予測では、がんと腫瘍は、がんの罹患率と治療法の拡大とともに、自己幹細胞治療の利用が増加しているため、予測期間中に最も高い成長が見込まれます。
北米は、慢性疾患の有病率の高さ、低侵襲治療への大きな需要の存在、有利な政府償還政策の利用可能性により、予測期間中に最も高い成長が見込まれています。
Autologous Stem Cell and Non-Stem Cell Based Therapy Trends and Forecast
The future of the global autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets. The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.
A more than 150-page report is developed to help in your business decisions.
Autologous Stem Cell and Non-Stem Cell Based Therapy by Segment
The study includes a forecast for the global autologous stem cell and non-stem cell based therapy by product type, type, application, end use, and region.
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Autologous Stem Cell and Non-Stem Cell Based Therapy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies autologous stem cell and non-stem cell based therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autologous stem cell and non-stem cell based therapy companies profiled in this report include-
Autologous Stem Cell and Non-Stem Cell Based Therapy Market Insights
Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.
North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.
Features of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
Market Size Estimates: Autologous stem cell and non-stem cell based therapy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Autologous stem cell and non-stem cell based therapy market size by various segments, such as by product type, type, application, end use, and region in terms of ($B).
Regional Analysis: Autologous stem cell and non-stem cell based therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, types, applications, end uses, and regions for the autologous stem cell and non-stem cell based therapy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autologous stem cell and non-stem cell based therapy market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the autologous stem cell and non-stem cell based therapy market size?
Answer: The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030.
Q.2 What is the growth forecast for autologous stem cell and non-stem cell based therapy market?
Answer: The global autologous stem cell and non-stem cell based therapy market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the autologous stem cell and non-stem cell based therapy market?
Answer: The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.
Q4. What are the major segments for autologous stem cell and non-stem cell based therapy market?
Answer: The future of the autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets.
Q5. Who are the key autologous stem cell and non-stem cell based therapy market companies?
Answer: Some of the key autologous stem cell and non-stem cell based therapy companies are as follows:
Q6. Which autologous stem cell and non-stem cell based therapy market segment will be the largest in future?
Answer: Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.
Q7. In autologous stem cell and non-stem cell based therapy market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.